The evaluation of a new anti-seborrhoeic formulation.
D000505:Alopecia / Q000628:therapy*; D002626:Chemistry, Pharmaceutical; D012628:Dermatitis, Seborrheic / Q000628:therapy*; D006571:Heterocyclic Compounds / Q000627:therapeutic use*; D006801:Humans
D006571:Heterocyclic Compounds
ALOPECIA/therapy; DERMATITIS SEBORRHEICA/therapy; HETEROCYCLIC COMPOUNDS/therapeutic use